Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website. 
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

2012

Half Year Report 2012

10/09/2012

Progetto di Bilancio d' Esercizio al 31 dicembre 2011

31/05/2012

Annual Report 2011

31/05/2012

Media, investor and analyst conference - 2011 results presentation

31/05/2012

Media, investors and analyst conference - 2011 results MP3 file

31/05/2012